jcm-logo

Journal Browser

Journal Browser

Clinical Features and Management of Psychosis

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Mental Health".

Deadline for manuscript submissions: 23 November 2025 | Viewed by 1192

Special Issue Editors


E-Mail
Guest Editor
1st Department of Psychiatry, Medical School, National and Kapodistrian University of Athens, 11528 Athens, Greece
Interests: psychopathology of psychosis; acute psychosis; schizophrenia; psychiatric education; mental health services

E-Mail
Guest Editor
1st Department of Psychiatry, Medical School, National and Kapodistrian University of Athens, 11528 Athens, Greece
Interests: clinical psychopathology; insight; cognitive impairment; social cognition; metacognition

E-Mail
Guest Editor
Department of Mental Health and Behavioral Sciences, Faculty of Nursing, National and Kapodistrian University of Athens, Athens, Greece
Interests: schizophrenia; bipolar disorder; neurobiology of psychosis; evidence based mental health

Special Issue Information

Dear Colleagues,

Psychosis is a clinical syndrome characterized by the presence of core clinical features such as delusions, hallucinations, affective symptoms, and disorganized thought and behavior. Its symptoms include—but are not limited to—impaired reality testing, communication disorders, lack of insight, and reduced social adaptation. Psychosis is the defining feature of schizophrenia spectrum disorders; it is also a common but variable feature of mood and substance use disorders and a relatively common feature of many developmental/degenerative neurologic and medical disorders. Across these conditions, psychosis signifies a greater severity of disease and contributes substantially to suffering, functional disability, and psychosocial impairment; therefore, it represents an important target for evaluation and treatment.

While there are some insights into the etiopathology and pathophysiology of psychotic symptoms, as of now, we are not aware of the exact biological mechanisms for explaining the pathophysiology of psychotic manifestations. The diagnosis of psychosis relies solely on clinical investigation and observation. The distribution, however, of psychotic symptoms across psychotic disorders is not homogenous, exhibiting intra-diagnostical heterogeneity as well as changes in symptom profiles over the course of illness; therefore, it is suggestive of a psychotic continuum of varied pathophysiology.

The aim of this Special Issue is (a) to promote and highlight research on the psychopathology of psychosis across diagnostic entities and illness course, and (b) to explore interventions and treatments based on stratification strategies of clinical features, along with environmental and endogenous factors, regardless of the diagnosis.

In this Issue, we welcome original research articles and review articles addressing the following topics:

  1. The common phenomenological characteristics of psychotic symptoms and other clinical manifestations of psychosis, their differences in the context of diverse diagnoses and illness course, as well as their impact on prognosis and treatment outcome.
  2. The specification of differential characteristics and deconstruction of common psychotic symptoms that could feasibly facilitate correspondence to neurobiological findings.
  3. The therapeutic management of psychosis in the context of diverse diagnosis, including medication, psychosocial, and psychotherapeutic interventions addressing its clinical manifestations and consequences.
  4. The transdiagnostical identification of clinical features or constellations of clinical features that could predict the optimal treatment response under specific therapeutic management.

Dr. Maria Margariti
Dr. George Konstantakopoulos
Dr. Michael Hadjulis
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • psychosis
  • clinical features of psychosis
  • diagnosis of psychosis
  • schizophrenia
  • psychotic depression
  • affective disorder with psychotic features
  • psychosis in substance use disorders
  • psychosis in neurological disorders
  • psychosis in medical conditions
  • management of psychosis
  • treatment of psychosis

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

11 pages, 227 KiB  
Article
Long-Acting Injectable Antipsychotic Use in Children and Adolescents in Comparison to Adults
by Iris Anja Levy, Joseph Lipton, Yoav Kohen and Alex Gizunterman
J. Clin. Med. 2025, 14(14), 5086; https://doi.org/10.3390/jcm14145086 - 17 Jul 2025
Viewed by 258
Abstract
Objective: The aim of the study was to assess the effectiveness and safety of long-acting injectable anti-psychotic treatment (LAIA) amongst children and adolescents. Given the difficulty of performing an randomized controlled trial (RCT), we suggested comparing children and adolescents to young adults who [...] Read more.
Objective: The aim of the study was to assess the effectiveness and safety of long-acting injectable anti-psychotic treatment (LAIA) amongst children and adolescents. Given the difficulty of performing an randomized controlled trial (RCT), we suggested comparing children and adolescents to young adults who were treated with LAIAs, and extrapolating data regarding efficacy and safety. Method: We compared data from medical files of adult inpatients treated with LAIAs to children and adolescent inpatients treated with LAIAs, between January 2014 and April 2021. Results: clinical global impression (CGI) scale score and rate of side effects (79% vs. 92%, p-value = 0.106) were not different between children and adolescents and young adults treated with LAIAs. There were no significant differences found between the groups in most demographic and clinical parameters such as gender distribution, legal status (voluntary or involuntary hospitalization), first hospitalizations and subsequent hospitalizations. Significant differences were found in duration of hospitalizations (144 days vs.50 days, p-value < 0.001), the indication for recommending LAIA treatment, diagnosis, the distribution of specific LAIAs and the rates of patients treated for side effects of anti-psychotic treatment. Conclusions: Results suggest that LAIA treatment may be as effective amongst children and adolescents as it is for adults. More research should be done to assess safety and efficacy of LAIA treatment in children and adolescents in the short and long term. Full article
(This article belongs to the Special Issue Clinical Features and Management of Psychosis)
18 pages, 6324 KiB  
Article
The Value of Structural Neuroimaging in First-Episode Psychosis and the Prevalence of Imaging Abnormalities and Clinical Relevance: A Real-World Observational Study
by José Pablo Martínez Barbero, José Tortosa Cámara, Beatriz Ramos Barbosa, Paula María Jiménez Gutiérrez, Manuel González Díez, José Eduardo Muñoz Negro, José Prados and Antonio Jesús Láinez Ramos-Bossini
J. Clin. Med. 2025, 14(14), 4925; https://doi.org/10.3390/jcm14144925 - 11 Jul 2025
Viewed by 488
Abstract
Introduction: The usefulness of neuroimaging in patients with first-episode psychosis (FEP) remains controversial. The aim of this study was to assess the prevalence and types of structural abnormalities on neuroimaging in patients with FEP and identify the most frequently used imaging modalities [...] Read more.
Introduction: The usefulness of neuroimaging in patients with first-episode psychosis (FEP) remains controversial. The aim of this study was to assess the prevalence and types of structural abnormalities on neuroimaging in patients with FEP and identify the most frequently used imaging modalities in a real-world setting. Methodology: A retrospective observational study based on a consecutive series of patients admitted to our institution with FEP was conducted. We analyzed the imaging tests performed, the presence of specific lesions, the degree of cortical atrophy (Global Cortical Atrophy, GCA scale), medial temporal atrophy (Medial Temporal lobe Atrophy, MTA scale) and non-specific white matter lesions (Fazekas scale). Descriptive and bivariate analyses were performed according to previously established age cut-offs. Results: A total of 105 patients were included (median age: 36 years; 52.4% men). The most frequently used neuroimaging test was computed tomography (CT) (92.4%). GCA scores that were out of the age range were found in 32.4% of patients, being more frequent in those older than 65 years (p < 0.001). Out-of-range MTA scores were found in 36.2% of patients, especially in patients older than 75 years (p < 0.001). Out-of-range Fazekas scores were found in 4.3% of patients, especially in patients older than 70 years (p = 0.157). Finally, only one specific structural lesion (right frontal cavernoma) was identified in one patient (1%). Overall, at least one non-age-matched abnormality was found in 46.7% of patients. Conclusions: Although non-specific alterations not in accordance with age exist in a significant percentage of patients with FEP, the prevalence of specific lesions is very low. This suggests that neuroimaging tests could be restricted in patients with FEP, especially CT, due to the risks associated with ionizing radiation. However, further prospective and controlled studies are needed to validate our results. Full article
(This article belongs to the Special Issue Clinical Features and Management of Psychosis)
Show Figures

Figure 1

Back to TopTop